10/15/2020
3:47 PM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/02/2020
8:00 PM | Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2020
9:44 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2020
10:17 AM | Adaptimmune Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2020
6:37 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/04/2020
8:02 PM | Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/04/2020
8:02 PM | Adaptimmune Therapeutics (Issuer)
TAYTON-MARTIN HELEN KATRINA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/04/2020
8:01 PM | Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2020
4:13 PM | Adaptimmune Therapeutics (Issuer)
Behbahani Ali (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2020
4:10 PM | Adaptimmune Therapeutics (Issuer)
Zaks Tal Zvi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
07/01/2020
4:09 PM | Adaptimmune Therapeutics (Issuer)
Alleva Lawrence M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2020
4:09 PM | Adaptimmune Therapeutics (Issuer)
Furey John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2020
4:08 PM | Adaptimmune Therapeutics (Issuer)
Noble James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2020
4:07 PM | Adaptimmune Therapeutics (Issuer)
Sigal Charles Elliott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2020
4:07 PM | Adaptimmune Therapeutics (Issuer)
MOTT DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2020
4:06 PM | Adaptimmune Therapeutics (Issuer)
Duncan Barbara Gayle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2020
8:01 PM | Adaptimmune Therapeutics (Issuer)
Wood Gavin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2020
8:00 PM | Adaptimmune Therapeutics (Issuer)
Alleva Lawrence M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2020
8:30 PM | Adaptimmune Therapeutics (Issuer)
Noble James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2020
4:05 PM | Adaptimmune Therapeutics (Filer)
| Form 424B5
| |
06/02/2020
3:49 PM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/01/2020
5:06 AM | Adaptimmune Therapeutics (Filer)
| Form 424B5
| |
05/29/2020
6:42 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2020
6:07 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2020
3:37 PM | Adaptimmune Therapeutics (Filer)
| Form 10-Q/A
| |
05/14/2020
10:02 AM | Adaptimmune Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2020
6:37 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2020
7:06 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2020
7:26 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/20/2020
7:00 AM | Adaptimmune Therapeutics (Filer)
| Form DEF 14A
| |
04/08/2020
7:06 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2020
7:00 AM | Adaptimmune Therapeutics (Filer)
| Form PRE 14A
| |
04/01/2020
6:06 PM | Adaptimmune Therapeutics (Issuer)
Noble James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2020
6:06 PM | Adaptimmune Therapeutics (Issuer)
Wood Gavin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2020
6:05 PM | Adaptimmune Therapeutics (Issuer)
Wood Gavin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/27/2020
10:50 AM | Adaptimmune Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2020
6:39 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/18/2020
7:07 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2020
3:20 PM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2020
3:52 PM | Adaptimmune Therapeutics (Issuer)
Florence Anthony A. Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2020
3:52 PM | Adaptimmune Therapeutics (Issuer)
Behbahani Ali (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2020
3:51 PM | Adaptimmune Therapeutics (Issuer)
BASKETT FOREST (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2020
4:31 PM | Adaptimmune Therapeutics (Filer)
| Form 424B5
| |
01/22/2020
4:30 PM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/21/2020
4:21 PM | Adaptimmune Therapeutics (Filer)
| Form 424B5
| |
01/17/2020
8:48 PM | Adaptimmune Therapeutics (Issuer)
Norry Elliot (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2020
8:35 PM | Adaptimmune Therapeutics (Issuer)
TAYTON-MARTIN HELEN KATRINA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2020
8:33 PM | Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2020
8:31 PM | Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2020
8:30 PM | Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2020
7:03 PM | Adaptimmune Therapeutics (Issuer)
Norry Elliot (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2020
7:03 PM | Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2020
7:02 PM | Adaptimmune Therapeutics (Issuer)
TAYTON-MARTIN HELEN KATRINA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2020
7:02 PM | Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2020
7:01 PM | Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2020
7:01 PM | Adaptimmune Therapeutics (Issuer)
Noble James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2020
5:17 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2020
7:02 PM | Adaptimmune Therapeutics (Issuer)
Norry Elliot (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/13/2020
7:42 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2020
6:09 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2020
7:01 PM | Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2020
7:01 PM | Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2020
7:00 PM | Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2019
10:55 AM | Adaptimmune Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2019
6:35 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2019
8:30 PM | Adaptimmune Therapeutics (Issuer)
Garone Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/01/2019
7:14 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2019
7:59 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2019
11:15 PM | Adaptimmune Therapeutics (Filer)
| Form EFFECT
| |
09/03/2019
8:00 PM | Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2019
12:06 PM | Adaptimmune Therapeutics (Subject)
Citibank,N.A./ADR (Filed by)
| Form F-6EF
| |
08/30/2019
11:30 AM | Adaptimmune Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/30/2019
11:26 AM | Adaptimmune Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/27/2019
7:39 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2019
8:00 PM | Adaptimmune Therapeutics (Issuer)
Amado Rafael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2019
8:03 PM | Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2019
8:02 PM | Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/01/2019
10:59 AM | Adaptimmune Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2019
6:23 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2019
6:22 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/25/2019
7:07 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/22/2019
7:08 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2019
7:11 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2019
4:41 PM | Adaptimmune Therapeutics (Issuer)
MOTT DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
4:40 PM | Adaptimmune Therapeutics (Issuer)
Behbahani Ali (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
4:01 PM | Adaptimmune Therapeutics (Issuer)
Zaks Tal Zvi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
4:00 PM | Adaptimmune Therapeutics (Issuer)
Furey John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
4:00 PM | Adaptimmune Therapeutics (Issuer)
Kerr Giles Francis Bertram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
4:00 PM | Adaptimmune Therapeutics (Issuer)
Sigal Charles Elliott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
4:00 PM | Adaptimmune Therapeutics (Issuer)
Duncan Barbara Gayle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
4:00 PM | Adaptimmune Therapeutics (Issuer)
Alleva Lawrence M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2019
7:00 PM | Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2019
7:08 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2019
5:00 PM | Adaptimmune Therapeutics (Issuer)
Noble James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2019
7:11 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2019
1:57 PM | Adaptimmune Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2019
7:11 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2019
6:38 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2019
6:08 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2019
3:56 PM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
